Kansas Senate Bill SB135

Kansas 2023-2024 Regular Session

• Introduced: 2/1/23
• Refer: 2/2/23
• Failed: 4/30/24

Caption

Creating the medical cannabis regulation act to regulate the cultivation, processing, distribution, sale and use of medical cannabis.

Impact

If passed, SB135 will significantly alter current state laws regarding medical cannabis. It will protect licensed cannabis users from discrimination in terms of employment and housing, preventing businesses from denying services based on cannabis consumption in compliance with the law. This could empower patients managing chronic conditions to have legal protections while engaging in real estate transactions, educational opportunities, and healthcare services. By regulating the industry, the bill also anticipates boosting state revenue through taxation and potentially reducing illegal cannabis activities by providing a legal avenue for patients and caregivers.

Summary

SB135 introduces comprehensive regulations for the cultivation, distribution, and sale of medical cannabis in the state. It aims to establish a clear framework for licensing retail dispensaries, laboratories, and cultivation facilities while imposing a 10% tax on cannabis sales. The bill outlines the responsibilities of the Director of Alcohol and Cannabis Control in overseeing these operations, including the collection of taxes and enforcement of regulatory compliance. This legislation also provides mechanisms for patient and caregiver registrations, emphasizing the rights of these individuals to possess and use medical cannabis within specified legal limits.

Contention

While the bill has garnered significant support for regulating an emerging industry and providing necessary protections to users, notable points of contention have arisen. Opponents argue that the constraints on who can access medical cannabis and the extensive regulation of its sale may not go far enough in ensuring equitable access for all patients, especially those from marginalized communities. Additionally, there are concerns regarding the effectiveness of enforcement and oversight by the appointed Director of Alcohol and Cannabis Control, particularly about ensuring that the cannabis market operates safely and without undue influence from larger corporate interests.